Drug intelligence / Profile preview

iron(III)-hydroxide polymaltose complex + folic acid

Development stage
Unknown
Lead developer
CSL Vifor
Modality
Small Molecules
Administration
Oral
01

Overview

Maltofer Fol is an oral antianemic combination therapy developed by CSL Vifor. It is formulated as a chewable tablet containing 100 mg of elemental iron in the form of iron(III)-hydroxide polymaltose complex (IPC) and 0.35 mg (350 micrograms) of folic acid. The IPC component provides a stable, non-ionic form of iron that is actively absorbed in the intestine via physiological pathways, which helps minimize the gastrointestinal side effects often associated with traditional ferrous salts. The iron component is utilized for hemoglobin synthesis and the replenishment of iron stores, while the folic acid component supports nucleic acid synthesis and helps prevent megaloblastic anemia and neural tube defects in the developing fetus. Maltofer Fol is primarily indicated for the treatment and prevention of iron deficiency and iron deficiency anemia, particularly during pregnancy and lactation.

Brand names
Maltofer Fol
Other names
IPC + folic acidiron polymaltose complex + folic acid
02

Targets

NeuraminidaseHb-heme (Hemoglobin heme iron site)DHFR (Dihydrofolate reductase)

Beyond the preview

Go deeper on iron(III)-hydroxide polymaltose complex + folic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on iron(III)-hydroxide polymaltose complex + folic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call